AR003003A1 - Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo. - Google Patents

Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo.

Info

Publication number
AR003003A1
AR003003A1 ARP960102975A AR10297596A AR003003A1 AR 003003 A1 AR003003 A1 AR 003003A1 AR P960102975 A ARP960102975 A AR P960102975A AR 10297596 A AR10297596 A AR 10297596A AR 003003 A1 AR003003 A1 AR 003003A1
Authority
AR
Argentina
Prior art keywords
virus
marek
cultivating
vaccine
protection
Prior art date
Application number
ARP960102975A
Other languages
English (en)
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of AR003003A1 publication Critical patent/AR003003A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención está relacionada con el virus de la enfermedad de Marek adaptado para ser cultivado sobre una línea celular avícola contínua, enparticular sobre la línea celular de codorniz QT-35, con la proliferación de los virus asíadaptados sobre cultivos celulares avícolas contínuos, y convacunas que contienen estos virus.
ARP960102975A 1995-06-12 1996-06-06 Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo. AR003003A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201540 1995-06-12

Publications (1)

Publication Number Publication Date
AR003003A1 true AR003003A1 (es) 1998-05-27

Family

ID=8220371

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102975A AR003003A1 (es) 1995-06-12 1996-06-06 Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo.

Country Status (13)

Country Link
US (1) US5789231A (es)
EP (1) EP0748867A1 (es)
JP (1) JPH0998778A (es)
CN (1) CN1147015A (es)
AR (1) AR003003A1 (es)
AU (1) AU5240896A (es)
BR (1) BR9602719A (es)
CA (1) CA2178553A1 (es)
HU (1) HUP9601608A2 (es)
IL (1) IL118613A0 (es)
MX (1) MX9602256A (es)
TR (1) TR199600502A1 (es)
ZA (1) ZA964878B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0884382A3 (en) * 1997-06-10 2000-10-25 Pfizer Products Inc. Processes for preparation of marek's disease virus using continuous mammalian cell lines
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
US6410222B1 (en) 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
AU2003206861B2 (en) * 2002-02-06 2009-04-23 Lohmann Animal Health Gmbh & Co. Kg A continuous cell line for the production of vaccines
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
US20070111211A1 (en) * 2003-12-30 2007-05-17 Virumar Pituach Tarkivim Ltd. Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
CN101365484A (zh) 2005-08-15 2009-02-11 瓦克辛公司 通过给药非复制型载体化疫苗而进行的对禽类的免疫
WO2009137146A2 (en) * 2008-02-25 2009-11-12 Baxter International Inc. Method for producing continuous cell lines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US4071618A (en) * 1974-09-03 1978-01-31 Research Foundation For Microbial Diseases Of Osaka University Process for preparing virus disease live vaccines
EP0015074B1 (en) * 1979-02-06 1983-07-20 Sigmund Stokland Harvester-thresher
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Also Published As

Publication number Publication date
JPH0998778A (ja) 1997-04-15
BR9602719A (pt) 1998-04-22
US5789231A (en) 1998-08-04
MX9602256A (es) 1997-01-31
IL118613A0 (en) 1996-10-16
ZA964878B (en) 1997-01-07
HUP9601608A2 (en) 1997-03-28
CA2178553A1 (en) 1996-12-13
HU9601608D0 (en) 1996-07-29
CN1147015A (zh) 1997-04-09
AU5240896A (en) 1997-01-02
EP0748867A1 (en) 1996-12-18
TR199600502A1 (tr) 1996-12-21

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
BR9605153A (pt) Vacina de combinação para uso na proteção de galináceos contra a doença de newcastle kit de vacinação para imunizar galináceos contra a doença de newcastle e processo para a prevenção da doença de newcastle em galináceos
DE69327585T2 (de) Befruchtete muscheleier enthaltende zusammensetzung
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
AU4951196A (en) Vaccines for plague
CO5011037A1 (es) Metodo para mejorar la condicion de la piel de un usuario en el area cubierta por un articulo absorbente
AR003003A1 (es) Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo.
CO4940430A1 (es) Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales
DE69028320D1 (de) Illudin-analoge, verwendet als antitumormittel
AR010794A1 (es) Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ES2061165T3 (es) Vacuna para la proteccion de las aves de corral frente a la enfermedad de marek.
EP0775743A3 (en) Chicken cell liquid infected with Marek's disease virus
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
BR9706133A (pt) Mycoplasma synoviae atenuado vivo cultura microbiológica vacina para a proteção de aves domésticas processo para sua preparação e uso da cepa mycoplasma synoviae
AR007611A1 (es) Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek
DE69417717D1 (de) Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen
AR012944A1 (es) Preparacion de virus de la enfermedad de marek usando lineas de celulas continuas de mamifero
KR900017611A (ko) 개의 코로나 바이러스 백신
KR880002998A (ko) 가금류의 대장균증 백신
BR0003164A (pt) Mutante ndv, vacinas viva e inativada contra doença de newcastle em aves, uso de um mutante ndv, e, processo de proteção de aves contra nd
ES2062502T3 (es) Una proteina de factor i pura y un procedimiento para obtener dicha proteina.
ES2139549B1 (es) Vacuna anti-flexibacter maritimus (fm-95) para la prevencion de la enfermedad "flexibacteriosis marina" en rodaballo y peces salmonidos, y procedimiento de obtencion.
PT783319E (pt) Composicoes de peptidos de muramilo que inibem a replicacao do hiv